Ophthalmology Doctors in Pineville, LA Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Mr. James G Ralston, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 65 Medical Park Blvd, Ste 101, Pineville, LA 71360 Phone: 318-473-9958    Fax: 318-443-6935

Karren Russo, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010

James R Hardin, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy # 71, Pineville, LA 71360 Phone: 318-473-0100

Dr. Joshua Richard Ford, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010

Peggy H Gramates, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010

Dr. Martin Luther Laird Iv, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010

News Archive

Scientists identify new inherited form of Parkinson's disease

Scientists at the Helmholtz Zentrum München and the Technische Universität München working in cooperation with the Medical University of Vienna have identified a mutation associated with a inherited form of late-onset Parkinson's disease.

New app developed to promote the inclusion of people with intellectual disability

The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.

Metal complexes against coronavirus

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 3.42 million deaths worldwide. Despite the fact that there are vaccines for SARS-CoV-2, the emergence of new variants and the lack of adequate treatments have encouraged the search for new ways to combat this disease more effectively.

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.

OGT launches Cytocell FISH probes for glial tumours

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.

Read more Medical News

› Verified 4 days ago